HCPCS Level IIdrugActive
J2506
Inj pegfilgrast ex bio 0.5mg
BETOS: O1E
Effective: 2023-04-01
Referenced in 4 policies
Description
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Neulasta
Manufacturer
Amgen Inc
HCPCS Dosage
0.5 MG
Billing Units
12.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.